• Potassium Grifols 0.02 mEq/ml in glucose 3.3% and sodium chloride 0.3% solution for infusion

  Form: solution for infusion

  Active substance	Dosage
  POTASSIUM CHLORIDE	1,49 mg
  GLUCOSE MONOHYDRATE	36,3 mg
  SODIUM CHLORIDE	3 mg

  ATC code: B05B B05BB B05BB02

  Manufacturer: Laboratorios Grifols S.A.

• Potassium Grifols 0.02 mEq/ml in glucose 5% solution for infusion

  Form: solution for infusion

  Active substance	Dosage
  GLUCOSE	5000 mg
  POTASSIUM CHLORIDE	149 mg

  ATC code: B05B B05BB B05BB02

  Manufacturer: Laboratorios Grifols S.A.

• Potassium Grifols 0.02 meq/ml in sodium chloride 0.9% solution for infusion

  Form: solution for infusion

  Active substance	Dosage
  POTASSIUM CHLORIDE	149 mg
  SODIUM CHLORIDE	900 mg

  ATC code: B05B B05BB B05BB01

  Manufacturer: Laboratorios Grifols S.A.

• Potassium Grifols 0.04 mEq/mL in sodium chloride 0.9% solution for infusion

  Form: solution for infusion

  Active substance	Dosage
  POTASSIUM CHLORIDE	300 mg
  SODIUM CHLORIDE	900 mg

  ATC code: B05B B05BB B05BB01

  Manufacturer: Laboratorios Grifols S.A.

• Potassium Grifols 0.04 mEq/ml in glucose 3.3% and sodium chloride 0.3% solution for infusion

  Form: solution for infusion

  Active substance	Dosage
  POTASSIUM CHLORIDE	2,98 mg
  GLUCOSE MONOHYDRATE	36,3 mg
  SODIUM CHLORIDE	3 mg

  ATC code: B05B B05BB B05BB02

  Manufacturer: Laboratorios Grifols S.A.

• Potassium Grifols 0.04 mEq/ml in glucose 5% solution for infusion

  Form: solution for infusion

  Active substance	Dosage
  GLUCOSE	5000 mg
  POTASSIUM CHLORIDE	300 mg

  ATC code: B05B B05BB B05BB02

  Manufacturer: Laboratorios Grifols S.A.

• Potassium Kabi 0,02 mEq/mL in glucose 5% solution for infusion EFG

  Form: solution for infusion

  Active substance	Dosage
  POTASSIUM CHLORIDE	1,5 mg
  GLUCOSE MONOHYDRATE	55,0 mg

  ATC code: B05B B05BB B05BB02

  Manufacturer: Fresenius Kabi Espana, S.A.U.

• Potassium Kabi 0,02 mEq/mL in sodium chloride 0,9% solution for infusion EFG

  Form: solution for infusion

  Active substance	Dosage
  POTASSIUM CHLORIDE	1,50 mg
  SODIUM CHLORIDE	9 mg

  ATC code: B05B B05BB B05BB01

  Manufacturer: Fresenius Kabi Espana, S.A.U.

• Potassium Kabi 0.04 meq/ml in glucose 5% solution for infusion EFG

  Form: solution for infusion

  Active substance	Dosage
  POTASSIUM CHLORIDE	3,0 mg
  GLUCOSE MONOHYDRATE	55,0 mg

  ATC code: B05B B05BB B05BB02

  Manufacturer: Fresenius Kabi Espana, S.A.U.

• Potassium Kabiven 0.04 mEq/mL in sodium chloride 0.9% solution for infusion EFG

  Form: solution for infusion

  Active substance	Dosage
  POTASSIUM CHLORIDE	3 mg
  SODIUM CHLORIDE	9 mg

  ATC code: B05B B05BB B05BB01

  Manufacturer: Fresenius Kabi Espana, S.A.U.

• Potassium acetate B. Braun 1 mEq/ml concentrate for infusion solution

  Form: solution for infusion, concentrate

  Active substance	Dosage
  POTASSIUM ACETATE	980 mg

  ATC code: B05X B05XA B05XA17

  Manufacturer: B Braun Medical S.A.

• Potassium chloride Braun 1 mEq/ml concentrate for infusion solution

  Form: solution for infusion

  Active substance	Dosage
  POTASSIUM CHLORIDE	7,45 mg

  ATC code: B05X B05XA B05XA01

  Manufacturer: B Braun Medical S.A.

• Potassium chloride Braun 2 mEq/ml concentrate for infusion solution

  Form: solution for infusion, concentrate

  Active substance	Dosage
  POTASSIUM CHLORIDE	14,9 g

  ATC code: B05X B05XA B05XA01

  Manufacturer: B Braun Medical S.A.

• Potassium chloride Kabi 0,02 mEq/mL in glucose 3,3% and sodium chloride 0,3% solution for infusion

  Form: solution for infusion

  Active substance	Dosage
  POTASSIUM CHLORIDE	1,50 mg
  GLUCOSE MONOHYDRATE	36 mg
  SODIUM CHLORIDE	3,30 mg

  ATC code: B05B B05BB B05BB02

  Manufacturer: Fresenius Kabi Espana, S.A.U.

• Potassium chloride Kabi 0.04 meq/ml in glucose 3.3% and sodium chloride 0.3% solution for infusion

  Form: solution for infusion

  Active substance	Dosage
  GLUCOSE MONOHYDRATE	36 mg
  SODIUM CHLORIDE	3,30 mg
  POTASSIUM CHLORIDE	3 mg

  ATC code: B05B B05BB B05BB02

  Manufacturer: Fresenius Kabi Espana, S.A.U.

• Potassium chloride Meinsol 2 mEq/ml concentrate for infusion solution

  Form: solution for infusion, concentrate

  Active substance	Dosage
  POTASSIUM CHLORIDE	14,9 g

  ATC code: B05X B05XA B05XA01

  Manufacturer: Fresenius Kabi Espana, S.A.U.

• Potassium chloride Serraclinics 2 mEq/ml concentrate for infusion solution

  Form: solution for infusion, concentrate

  Active substance	Dosage
  POTASSIUM CHLORIDE	150 mg

  ATC code: B05X B05XA B05XA01

  Manufacturer: Laboratorios Serra Pamies S.A.

• Poteligeo 4 mg/ml concentrate for infusion solution

  Form: solution for infusion, concentrate

  Active substance	Dosage
  MOGAMULIZUMAB	20 mg

  ATC code: L01F L01FX L01FX09

  Manufacturer: Kyowa Kirin Holdings B.V.

• Potenciator 5 g oral solution

  Form: solution, oral

  Active substance	Dosage
  ASPARTIC ACID ARGININE	5 g

  ATC code: A16A A16AA

  Manufacturer: Faes Farma S.A.

• Pradaxa 110 mg coated granules

  Form: granules, coated

  Active substance	Dosage
  DABIGATRAN ETEXILATE MESYLATE	126,83 mg

  ATC code: B01A B01AE B01AE07

  Manufacturer: Boehringer Ingelheim International Gmbh

• Pradaxa 110 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  DABIGATRAN ETEXILATE MESYLATE	110 mg

  ATC code: B01A B01AE B01AE07

  Manufacturer: Boehringer Ingelheim International Gmbh

• Pradaxa 110 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  DABIGATRAN ETEXILATE MESYLATE	110 mg

  ATC code: B01A B01AE B01AE07

  Manufacturer: Boehringer Ingelheim International Gmbh

• Pradaxa 110 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  DABIGATRAN ETEXILATE MESYLATE	110 mg

  ATC code: B01A B01AE B01AE07

  Manufacturer: Boehringer Ingelheim International Gmbh

• Pradaxa 150 mg granules for oral suspension

  Form: granules, coated

  Active substance	Dosage
  DABIGATRAN ETEXILATE MESYLATE	172,95 mg

  ATC code: B01A B01AE B01AE07

  Manufacturer: Boehringer Ingelheim International Gmbh

• Pradaxa 150 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  DABIGATRAN ETEXILATE MESYLATE	172,95 mg

  ATC code: B01A B01AE B01AE07

  Manufacturer: Boehringer Ingelheim International Gmbh

• Pradaxa 20 mg granules, coated

  Form: granules, coated

  Active substance	Dosage
  DABIGATRAN ETEXILATE MESYLATE	23,06 mg

  ATC code: B01A B01AE B01AE07

  Manufacturer: Boehringer Ingelheim International Gmbh

• Pradaxa 30 mg granules coated

  Form: granules, coated

  Active substance	Dosage
  DABIGATRAN ETEXILATE MESYLATE	34,59 mg

  ATC code: B01A B01AE B01AE07

  Manufacturer: Boehringer Ingelheim International Gmbh

• Pradaxa 40 mg coated granules

  Form: granules, coated

  Active substance	Dosage
  DABIGATRAN ETEXILATE MESYLATE	46,12 mg

  ATC code: B01A B01AE B01AE07

  Manufacturer: Boehringer Ingelheim International Gmbh

• Pradaxa 50 mg coated granules

  Form: granules, coated

  Active substance	Dosage
  DABIGATRAN ETEXILATE MESYLATE	57,65 mg

  ATC code: B01A B01AE B01AE07

  Manufacturer: Boehringer Ingelheim International Gmbh

• Pradaxa 75 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  DABIGATRAN ETEXILATE MESYLATE	75 mg

  ATC code: B01A B01AE B01AE07

  Manufacturer: Boehringer Ingelheim International Gmbh

• Pradaxa 75 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  DABIGATRAN ETEXILATE MESYLATE	75 mg

  ATC code: B01A B01AE B01AE07

  Manufacturer: Boehringer Ingelheim International Gmbh

• Praluent 150 mg solution for injection in pre-filled pen

  Form: solution for injection

  Active substance	Dosage
  ALIROCUMAB	150 mg

  ATC code: C10A C10AX C10AX14

  Manufacturer: Sanofi Winthrop Industrie

• Praluent 300 mg solution for injection in pre-filled pen

  Form: solution for injection in pre-filled pen

  Active substance	Dosage
  ALIROCUMAB	300 mg

  ATC code: C10A C10AX C10AX14

  Manufacturer: Sanofi Winthrop Industrie

• Praluent 75 mg solution for injection in pre-filled pen

  Form: solution for injection

  Active substance	Dosage
  ALIROCUMAB	75 mg

  ATC code: C10A C10AX C10AX14

  Manufacturer: Sanofi Winthrop Industrie

• Pramep 20 mg/ml oral solution EFG

  Form: solution, oral

  Active substance	Dosage
  PREGABALINE	20 mg

  ATC code: N02B N02BF N02BF02

  Manufacturer: Laboratorio Stada S.L.

• Pramipexole Aurovitas 0.18 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  Pramipexole Dihydrochloride Monohydrate	0,250 mg

  ATC code: N04B N04BC N04BC05

  Manufacturer: Aurovitas Spain, S.A.U.

• Pramipexole Aurovitas 0.7 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  Pramipexole Dihydrochloride Monohydrate	1,000 mg

  ATC code: N04B N04BC N04BC05

  Manufacturer: Aurovitas Spain, S.A.U.

• Pramipexole Aurovitas Spain 0.26 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  Pramipexole Dihydrochloride Monohydrate	0,375 mg

  ATC code: N04B N04BC N04BC05

  Manufacturer: Aurovitas Spain, S.A.U.

• Pramipexole Aurovitas Spain 1.05 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  Pramipexole Dihydrochloride Monohydrate	1,5 mg

  ATC code: N04B N04BC N04BC05

  Manufacturer: Aurovitas Spain, S.A.U.

• Pramipexole Aurovitas Spain 2.1 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  Pramipexole Dihydrochloride Monohydrate	3 mg

  ATC code: N04B N04BC N04BC05

  Manufacturer: Aurovitas Spain, S.A.U.

• Pramipexole CINFA 0.18 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  Pramipexole Dihydrochloride Monohydrate	0,18 mg

  ATC code: N04B N04BC N04BC05

  Manufacturer: Laboratorios Cinfa S.A.

• Pramipexole CINFA 0.52 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  Pramipexole Dihydrochloride Monohydrate	0,75 mg

  ATC code: N04B N04BC N04BC05

  Manufacturer: Laboratorios Cinfa S.A.

• Pramipexole CINFA 0.7 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  Pramipexole Dihydrochloride Monohydrate	0,7 mg

  ATC code: N04B N04BC N04BC05

  Manufacturer: Laboratorios Cinfa S.A.

• Pramipexole CINFA 1.57 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  Pramipexole Dihydrochloride Monohydrate	2,25 mg

  ATC code: N04B N04BC N04BC05

  Manufacturer: Laboratorios Cinfa S.A.

• Pramipexole CINFA 2.62 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  Pramipexole Dihydrochloride Monohydrate	3,75 mg

  ATC code: N04B N04BC N04BC05

  Manufacturer: Laboratorios Cinfa S.A.

• Pramipexole Cinfa 0.26 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  Pramipexole Dihydrochloride Monohydrate	0,375 mg

  ATC code: N04B N04BC N04BC05

  Manufacturer: Laboratorios Cinfa S.A.

• Pramipexole Cinfa 2.1 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  Pramipexole Dihydrochloride Monohydrate	3 mg

  ATC code: N04B N04BC N04BC05

  Manufacturer: Laboratorios Cinfa S.A.

• Pramipexole Cinfa 3.15 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  Pramipexole Dihydrochloride Monohydrate	4,5 mg

  ATC code: N04B N04BC N04BC05

  Manufacturer: Laboratorios Cinfa S.A.

• Pramipexole Cinfac 1.05 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  Pramipexole Dihydrochloride Monohydrate	1,5 mg

  ATC code: N04B N04BC N04BC05

  Manufacturer: Laboratorios Cinfa S.A.

• Pramipexole Kern Pharma 0.18 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  PRAMIPEXOL	0,18 mg

  ATC code: N04B N04BC N04BC05

  Manufacturer: Kern Pharma S.L.